EZH2 promotes proliferation and invasiveness of prostate cancer cells
暂无分享,去创建一个
F. Hamdy | R. Bryant | N. Cross | C. Eaton | V. Cunliffe | F. Hamdy | R.J. Bryant | N.A. Cross | C.L. Eaton | F.C. Hamdy | V.T. Cunliffe
[1] T. Ochiya,et al. Efficient delivery of small interfering RNA to bone-metastatic tumors by using atelocollagen in vivo. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[2] P. V. van Diest,et al. Poorly differentiated breast carcinoma is associated with increased expression of the human polycomb group EZH2 gene. , 2003, Neoplasia.
[3] John T. Wei,et al. Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression. , 2005, Cancer cell.
[4] B. Ness,et al. The polycomb group protein enhancer of zeste homolog 2 (EZH2) is an oncogene that influences myeloma cell growth and the mutant ras phenotype , 2005, Oncogene.
[5] K. Helin,et al. Polycomb Group Proteins in Cell Cycle Progression and Cancer , 2004, Cell cycle.
[6] T. Utsunomiya,et al. Clinicopathological significance of EZH2 mRNA expression in patients with hepatocellular carcinoma , 2005, British Journal of Cancer.
[7] A. Otte,et al. Gene repression by Polycomb group protein complexes: a distinct complex for every occasion? , 2003, Current opinion in genetics & development.
[8] Tapio Visakorpi,et al. The gene for polycomb group protein enhancer of zeste homolog 2 (EZH2) is amplified in late‐stage prostate cancer , 2006, Genes, chromosomes & cancer.
[9] C. Allis,et al. Translating the Histone Code , 2001, Science.
[10] J. Köllermann,et al. Expression levels of the EZH2 polycomb transcriptional repressor correlate with aggressiveness and invasive potential of bladder carcinomas. , 2005, International journal of molecular medicine.
[11] S. Merajver,et al. The Polycomb group protein EZH2 impairs DNA repair in breast epithelial cells. , 2005, Neoplasia.
[12] V. Rotter,et al. Activated p53 suppresses the histone methyltransferase EZH2 gene , 2004, Oncogene.
[13] C. Meijer,et al. Increased expression of the EZH2 polycomb group gene in BMI-1-positive neoplastic cells during bronchial carcinogenesis. , 2004, Neoplasia.
[14] R. Willemze,et al. The Polycomb group protein EZH2 is upregulated in proliferating, cultured human mantle cell lymphoma , 2001, British journal of haematology.
[15] Arul M Chinnaiyan,et al. Multiplex biomarker approach for determining risk of prostate-specific antigen-defined recurrence of prostate cancer. , 2003, Journal of the National Cancer Institute.
[16] Rosalind Eeles,et al. Transcription factor E2F3 overexpressed in prostate cancer independently predicts clinical outcome , 2004, Oncogene.
[17] C. Meijer,et al. Coexpression of BMI-1 and EZH2 polycomb-group proteins is associated with cycling cells and degree of malignancy in B-cell non-Hodgkin lymphoma. , 2001, Blood.
[18] Lei Ding,et al. Enhancer of Zeste 2 as a marker of preneoplastic progression in the breast. , 2006, Cancer research.
[19] N. Palavan-Unsal,et al. Increased Expression of EZH2, a Polycomb Group Protein, in Bladder Carcinoma , 2005, Urologia Internationalis.
[20] D. Tindall,et al. Androgen receptor signaling in androgen-refractory prostate cancer. , 2001, Journal of the National Cancer Institute.
[21] R. Hoffman,et al. Essential Role for Activation of the Polycomb Group (PcG) Protein Chromatin Silencing Pathway in Metastatic Prostate Cancer , 2006, Cell cycle.
[22] G. Murphy,et al. LNCaP model of human prostatic carcinoma. , 1983, Cancer research.
[23] D. Reinberg,et al. Composition and histone substrates of polycomb repressive group complexes change during cellular differentiation. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[24] R. Kingston,et al. Mechanisms of transcriptional memory , 2001, Nature Reviews Molecular Cell Biology.
[25] C. Kleer,et al. The Polycomb group protein Enhancer of Zeste 2: its links to DNA repair and breast cancer , 2006, Journal of Molecular Histology.
[26] Stephen A Boorjian,et al. Increased Expression of the Polycomb Group Gene, EZH2, in Transitional Cell Carcinoma of the Bladder , 2005, Clinical Cancer Research.
[27] S. Dhanasekaran,et al. The polycomb group protein EZH2 is involved in progression of prostate cancer , 2002, Nature.
[28] T. Golub,et al. Increased expression of genes converting adrenal androgens to testosterone in androgen-independent prostate cancer. , 2006, Cancer research.
[29] Kristian Helin,et al. EZH2 is downstream of the pRB‐E2F pathway, essential for proliferation and amplified in cancer , 2003, The EMBO journal.
[30] Debashis Ghosh,et al. EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[31] Christoph Wülfing,et al. Polycomb Group Protein Ezh2 Controls Actin Polymerization and Cell Signaling , 2005, Cell.
[32] K. Yanagihara,et al. Expression of the enhancer of zeste homolog 2 is correlated with poor prognosis in human gastric cancer , 2006, Cancer science.
[33] O. Hobert,et al. Interaction of Vav with ENX-1, a putative transcriptional regulator of homeobox gene expression , 1996, Molecular and cellular biology.
[34] Paul Tempst,et al. Different EZH2-containing complexes target methylation of histone H1 or nucleosomal histone H3. , 2004, Molecular cell.
[35] S. Merajver,et al. Identification of EZH2 as a molecular marker for a precancerous state in morphologically normal breast tissues. , 2006, Cancer research.
[36] M. Wirth,et al. Quantitative multi‐gene expression profiling of primary prostate cancer , 2006 .
[37] Johan Eide,et al. Expression of enhancer of zeste homologue 2 is significantly associated with increased tumor cell proliferation and is a marker of aggressive breast cancer. , 2006, Clinical cancer research : an official journal of the American Association for Cancer Research.
[38] C. Meijer,et al. Coexpression of BMI-1 and EZH2 polycomb group genes in Reed-Sternberg cells of Hodgkin's disease. , 2000, The American journal of pathology.
[39] V. Reinke,et al. Regulation of tissue-specific and extracellular matrix-related genes by a class I histone deacetylase. , 2005, Molecular cell.
[40] D. Hanahan,et al. The Hallmarks of Cancer , 2000, Cell.